A path forward to improving the specificity of immunotherapies
Clin Transl Med
.
2022 Sep;12(9):e1051.
doi: 10.1002/ctm2.1051.
Authors
Brittany Barber
1
,
Florian Mair
2
3
,
Martin Prlic
3
4
Affiliations
1
Department of Otolaryngology, University of Washington, Seattle, Washington.
2
Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Switzerland.
3
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States.
4
Department of Global Health, University of Washington, Seattle, Washington.
PMID:
36101938
PMCID:
PMC9471041
DOI:
10.1002/ctm2.1051
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
MeSH terms
Data Collection
Immunotherapy*
Grants and funding
R01 AI123323/AI/NIAID NIH HHS/United States
R56 DE032009/DE/NIDCR NIH HHS/United States